TransCon CNP, a Sustained-Release C-Type Natriuretic Peptide Prodrug, a Potentially Safe and Efficacious New Therapeutic Modality for the Treatment of Comorbidities Associated with Fibroblast Growth Factor Receptor 3–Related Skeletal Dysplasias

Vibeke Breinholt, C.E. Rasmussen, Per Mygind, Mads Kjelgaard‐Hansen, Frank Faltinger, Ana Bernhard, J. L. Zettler, Ulrich Hersel

Journal of Pharmacology and Experimental Therapeutics · 2019 · 63 citations · 14 references

DOIFull text

Open access

Concepts

References

14